TE Connectivity posts mixed Q3 results as medical market recovery continues

Medtech supplier TE Connectivity (NYSE: TEL) today released financial results for its fiscal Q3, falling short of analysts’ sales expectations but exceeding expected earnings.

Schaffhausen, Switzerland-based TE Connectivity said medical market performance in its industrial segment continues to improve. The company provides connectivity and sensor solutions for medical applications and a broad range of other industries.

“We delivered earnings above guidance, along with year-over-year sales growth in our Transportation and Industrial segments, as we continue to benefit from the strategic positioning of our portfolio around key growth and sustainability trends,” TE Connectivity CEO Terrence Curtin said in a news release. “Our leading global position in electric vehicles once again allowed us to deliver a strong performance in Transportation, and we continued to capitalize on growth momentum in renewable energy applications as well as ongoing market rec…

Read more
  • 0

TE Connectivity opens global medical device prototyping center in Ireland

TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland.

The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices.

Propelus has advanced engineering capabilities, including build-to-print services, quick turnaround prototype production and 3D printing. Engineers can work alongside customers to allow them to leave with a functional prototype and a detailed commercialization proposal. TE can also manufacture a final device at high volumes in one of its global manufacturing facilities to help manage supply chains.

“The principle is simple – getting high-quality prototypes into customers’ hands as quickly as possible. By improving the speed of product development and manufacturing, TE will help…

Read more
  • 0

TE Connectivity beats the Street with Q2 results

TE Connectivity (NYSE:TEL) posted second-quarter results today that beat the consensus forecast on Wall Street.

The Schaffhausen, Switzerland–based company provides connectivity and sensor solutions for a broad range of industries, including medtech.

TE Connectivity reported profits of $560 million, or $1.71 per diluted share, on sales of $4.0 billion for the three months ended March 25, 2022, for a bottom-line gain of nearly 11% and sales growth of 7% compared with Q2 2021.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

TE Connectivity beats the Street with Q2 results

TE Connectivity (NYSE:TEL) posted second-quarter results today that beat the consensus forecast on Wall Street.

The Schaffhausen, Switzerland–based company provides connectivity and sensor solutions for a broad range of industries, including medtech.

TE Connectivity reported profits of $560 million, or $1.71 per diluted share, on sales of $4.0 billion for the three months ended March 25, 2022, for a bottom-line gain of nearly 11% and sales growth of 7% compared with Q2 2021.

Adjusted to exclude one-time items, earnings per share were $1.81, $0.09 ahead of the Street, where analysts were looking for adjusted EPS of $1.72 on sales of $3.83 billion.

“I am very pleased with our strong second-quarter performance and our global team’s execution in delivering record sales and double-digit EPS growth that exceeded our expectations,” TE Connectivity CEO Terrence Curtin said in a news release. “All three of our business segments – transpor…

Read more
  • 0

TE Connectivity beats the Street in Q1

TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus forecast on Wall Street.

The Schaffhausen, Switzerland-based company reported profits of $566 million — or $1.72 per share — on sales of $3.8 billion for the fiscal quarter ended Dec. 24, 2021, for a bottom-line gain of nearly 49% and sales growth of 8.4% compared with Q1 2020.

Adjusted to exclude one-time items, earnings per share were $1.76, 16 cents ahead of the Street, where analysts were looking for EPS of $1.60 on sales of $3.73 billion.

“We continue to experience a strong global demand environment and our first quarter sales growth was driven by strong sales performance in our Industrial and Communications segments,” TE Connectivity CEO Terrence Curtin said in a news release. “We also continue to benefit from the strategic positioning of our portfolio and investment in innovation that is focused on growth and sustainability trends in electric ve…

Read more
  • 0

Women in Medtech 2021: Madhulika (Maddy) Srikanth, TE Connectivity Engineering Manager, R&D/Product Development Team

Madhulika (Maddy) Srikanth [Photo courtesy of TE Connectivity]

Dr. Madhulika (Maddy) Srikanth has been with TE Connectivity for over 5 years, working with the R&D/Product Development Team as an Engineering Manager.

Srikanth leads multiple projects and validation work with the R&D and product development team for minimally invasive medical device applications. She’s a creative visionary with a track record of key-development inputs in critical-to-business projects and acquisitions. 

Srikanth holds a PhD in Mechanical Engineering with her thesis in Biomedical Application of Nanomaterials from Wichita State University. She is a big soccer (football) and Formula-1 racing fan and during weekends enjoys spending time with her family and 2 dogs. 

What first drew you to medtech? When did you first know you wanted to be in the industry? Srikanth: As a teenager I…

Read more
  • 0

How a future-minded medtech engineer finds inspiration, innovation and creativity

Marie Ottum, principal R&D engineer in TE Connectivity’s Advanced Technology Group [Photo courtesy of Marie Ottum]The future of medtech is the focus of TE Connectivity’s Advanced Technology Group, a team of experienced engineers tasked with identifying trends and developing new technology for devices and challenges that might not yet even exist.

Marie Ottum, principal R&D engineer in TE Connectivity’s Advanced Technology Group and global leader of the TE women’s networking group, is an expert on single-use endoscopes who was recently featured on MassDevice’s DeviceTalks Tuesdays.

Medical Design & Outsourcing caught up with Ottum to learn more about how and where she finds inspiration, innovation and creativity.

Get the full story at our sister site Medical Design & Outsourcing.

Read more
  • 0

How a future-minded medtech engineer finds inspiration, innovation and creativity

Marie Ottum, principal R&D engineer in TE Connectivity’s Advanced Technology Group [Photo courtesy of Marie Ottum]

The future of medtech is the focus of TE Connectivity’s Advanced Technology Group, a team of experienced engineers tasked with identifying trends and developing new technology for devices and challenges that might not yet even exist.

Marie Ottum, principal R&D engineer in TE Connectivity’s Advanced Technology Group and global leader of the TE women’s networking group, is an expert on single-use endoscopes who was recently featured on MassDevice’s Device Talks Tuesday. 

Medical Design & Outsourcing caught up with Ottum to learn more about how and where she finds inspiration, innovation and creativity. (The following has been edited for space and clarity.)

TE Connectivity single-use bronchoscope [Photo courtesy of TE Con…

Read more
  • 0

TE Connectivity posts Street-beating Q1 results, medical sales dip 12%

TE Connectivity (NYSE:TEL) posted first-quarter results today that beat the consensus on Wall Street.

The Schaffhausen, Switzerland-based company reported profits of $381 million, or $1.13 per share, on sales of $3.5 billion for the three months ended Dec. 31, 2020, for a bottom-line gain of 1365.4% sales growth of 11.2% compared with Q1 2020.

Adjusted to exclude one-time items, earnings per share were $1.47, 19¢ ahead of The Street, where analysts were looking for sales of $3.3 billion.

Medical sales experienced a -12.8% decline for a loss of -$23 million, up slightly from Q1 2020 when the medical sector saw a -13.4% decline on -$24 million in sales losses.

“Our strong first-quarter performance reflects our global team’s ability to adapt to ongoing dynamic market conditions to deliver double-digit sales and EPS growth that exceeded our expectations,” CEO Terrence Curtain said in a news release. “These results demonstrate the strength and resilien…

Read more
  • 0